Foot drop treatment devices market seen reaching $3.59 billion by 2030

The Business Research Company says the foot drop treatment devices market will rise from $2.45 billion in 2025 to $2.65 billion in 2026, with growth supported by neurological disorders, stroke recovery needs and expanding rehabilitation care. The report flags North America as the largest market in 2025 and Asia-Pacific as the fastest-growing region through 2030.

Why it matters: - Foot drop treatment devices help people lift the front of the foot, reduce tripping risk and improve daily mobility. - Demand is rising as neurological disorders and stroke-related mobility problems become more common. - The market is also benefiting from broader use of rehabilitation services, orthotic devices and wearable medical technology.

What happened: - The Business Research Company released a market report on foot drop treatment devices on August 7, 2026. - The report estimates the market will grow from $2.45 billion in 2025 to $2.65 billion in 2026, an 8.1% CAGR. - The report forecasts the market will reach $3.59 billion by 2030, at a 7.9% CAGR. - A free sample of the report is available here. - The full report is available here.

The details: - Foot drop treatment devices are specialized aids for people who cannot lift the front part of the foot because of neurological or muscular disorders. - The devices keep the foot elevated during walking to prevent dragging or slapping. - The main clinical goals are better mobility, fewer falls and improved quality of life. - The report links market growth to rising neurological disorders, more stroke survivors with mobility challenges, more rehabilitation centers, wider orthotic availability and greater clinical awareness of foot drop. - The report says growth is also supported by adoption of advanced neurorehabilitation technology, homecare mobility aids, personalized orthotic solutions and wearable medical device innovation. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated technology and trend analysis.

Between the lines: - The report points to a market shaped by aging populations and better diagnosis of neurological conditions. - The rising burden of neurological disease creates a bigger pool of patients who may need mobility support devices. - North America’s lead suggests established rehab infrastructure still drives spending, while Asia-Pacific’s growth reflects rising access and investment.

What's next: - The market is expected to keep expanding through 2030 as home-based mobility care and personalized devices gain traction. - Continued innovation in wearable medical devices could widen adoption beyond traditional rehabilitation settings. - Further growth will likely depend on how quickly healthcare systems expand access to diagnostics, rehab and orthotic support.

The bottom line: - Foot drop treatment devices are moving from a niche rehabilitation category into a broader mobility-support market with steady global growth.